Recombinant multi-species ESR2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ESR2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the family of estrogen receptors and superfamily of nuclear receptor transcription factors. The gene product contains an N-terminal DNA binding domain and C-terminal ligand binding domain and is localized to the nucleus, cytoplasm, and mitochondria. Upon binding to 17beta-estradiol or related ligands, the encoded protein forms homo- or hetero-dimers that interact with specific DNA sequences to activate transcription. Some isoforms dominantly inhibit the activity of other estrogen receptor family members. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been fully characterized. [provided by RefSeq, Jul 2008]
The Alternative Names of target: ER-BETA,ER-beta,ERB,ERBETA,ER[b],ERbeta,ESR-BETA,ESR2,ESRB,ESTRB,Erb,Erb2,Esr2,Estrb,Estrogen receptor beta,NR3A2,Nuclear receptor subfamily 3 group A member 2,ODG8,er
Go
to ESR2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T80896-Ag-1/ GM-Tg-hg-T80896-Ag-2 | Human ESR2 protein | Human |
| GM-Tg-rg-T80896-Ag-1/ GM-Tg-rg-T80896-Ag-2 | Rat ESR2 protein | Rat |
| GM-Tg-mg-T80896-Ag-1/ GM-Tg-mg-T80896-Ag-2 | Mouse ESR2 protein | Mouse |
| GM-Tg-cynog-T80896-Ag-1/ GM-Tg-cynog-T80896-Ag-2 | Cynomolgus/Rhesus macaque ESR2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T80896-Ag-1/ GM-Tg-felg-T80896-Ag-2 | Feline ESR2 protein | Feline |
| GM-Tg-cang-T80896-Ag-1/ GM-Tg-cang-T80896-Ag-2 | Canine ESR2 protein | Canine |
| GM-Tg-bovg-T80896-Ag-1/ GM-Tg-bovg-T80896-Ag-2 | Bovine ESR2 protein | Bovine |
| GM-Tg-equg-T80896-Ag-1/ GM-Tg-equg-T80896-Ag-2 | Equine ESR2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T80896-Ag-1/ GM-Tg-hg-T80896-Ag-2;
GM-Tg-rg-T80896-Ag-1/ GM-Tg-rg-T80896-Ag-2;
GM-Tg-mg-T80896-Ag-1/ GM-Tg-mg-T80896-Ag-2; GM-Tg-cynog-T80896-Ag-1/ GM-Tg-cynog-T80896-Ag-2; GM-Tg-felg-T80896-Ag-1/ GM-Tg-felg-T80896-Ag-2; GM-Tg-cang-T80896-Ag-1/ GM-Tg-cang-T80896-Ag-2; GM-Tg-bovg-T80896-Ag-1/ GM-Tg-bovg-T80896-Ag-2; GM-Tg-equg-T80896-Ag-1/ GM-Tg-equg-T80896-Ag-2 |
| Products Name | ESR2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | ESR2 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ESR2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.